NCT02520947

Brief Summary

213 patients undergoing elective on-pump coronary artery bypass grafting (CABG) were enrolled into this prospective-clinical trial.After hundred and sixty three patients were excluded due to various reasons, 50 patients were randomized to BIS (bispectral index) and MAC (minimum alveolar concentration) groups. In BIS group (Group B, n=25), desflurane was titrated within 40 to 60 BIS values and in MAC group (Group M, n=25) within 0.7 to 1.3 MAC. Primary end point of the study was to investigate the difference of desflurane consumption between groups.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2014

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 13, 2015

Completed
Last Updated

August 13, 2015

Status Verified

August 1, 2015

Enrollment Period

9 months

First QC Date

August 5, 2015

Last Update Submit

August 12, 2015

Conditions

Keywords

desfluraneBIScoronary artery bypass grafting surgery

Outcome Measures

Primary Outcomes (1)

  • Total and hourly amounts of desflurane consumption

    A more than 20 % reduction in total and hourly amounts of desflurane consumption

    up to 12 hours

Secondary Outcomes (3)

  • Time to extubation

    up to 2 days

  • Mortality

    28 days

  • Morbidity

    28 days

Study Arms (2)

Bispectral index

EXPERIMENTAL

The group that desflurane titrated according to bispectral index monitoring

Device: BISDrug: Desflurane

Minimum alveolar concentration

OTHER

The group that desflurane consumption titrated according to minimum alveolar concentration monitoring

Drug: Desflurane

Interventions

BISDEVICE

Bispectral index monitoring

Also known as: processed electroencephalograpy
Bispectral index

volatile agent for maintenance of anesthesia

Also known as: suprane
Bispectral indexMinimum alveolar concentration

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing elective on-pump CABG surgery
  • Having an American Society of Anesthesiologists' (ASA) physical status of 3 to 4

You may not qualify if:

  • A contraindication to the administration of the study drugs
  • History of psychiatric and/or neurological disorder
  • A left ventricular ejection fraction (EF) \< 30%
  • A body mass index (BMI) \> 30 kg/ m2
  • Urgent surgery
  • Myocard infarction within 48 hours
  • Preoperative need for inotropic/vasodilator agents
  • History of heart surgery
  • Preoperative or intraoperative need for intraaortic balloon pump
  • Left ventricular aneurysms
  • Severe pulmonary, renal or hepatic dysfunction
  • Presence of excessive alcohol intake or drug abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Unconsciousness

Interventions

Desflurane

Condition Hierarchy (Ancestors)

Consciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ethyl EthersEthersOrganic ChemicalsMethyl EthersHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbons

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident

Study Record Dates

First Submitted

August 5, 2015

First Posted

August 13, 2015

Study Start

January 1, 2014

Primary Completion

October 1, 2014

Study Completion

November 1, 2014

Last Updated

August 13, 2015

Record last verified: 2015-08